Compare Stocks: FRX, MJN, CARA, and CRON

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CARA Cara Operations		C$0.00	C$21.20 ▼ C$29.88	C$1.62B	N/A	36,321 shs	35,304 shs
CRON Cronos Group	$3.12 -1.4%	$2.81	$2.28 ▼ $3.43	$1.15B	0.9	1.34 million shs	732,615 shs
FRX Fennec Pharmaceuticals	C$17.01	C$14.33	C$7.59 ▼ C$17.64	C$590.88M	3.548856	1,233 shs	403 shs
MJN Cronos Group	C$12.15 -1.9%	C$12.15	C$1.58 ▼ C$14.83	C$1.73B	N/A	2.07 million shs	1.39 million shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CARA Cara Operations	0.00%	0.00%	0.00%	0.00%	0.00%
CRON Cronos Group	-0.32%	+2.93%	+14.91%	+20.15%	+20.61%
FRX Fennec Pharmaceuticals	+3.03%	+13.40%	+15.01%	+27.80%	+35.97%
MJN Cronos Group	0.00%	0.00%	0.00%	0.00%	0.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CARA Cara Operations		C$0.00	C$21.20 ▼ C$29.88	C$1.62B	N/A	36,321 shs	35,304 shs
CRON Cronos Group	$3.12 -1.4%	$2.81	$2.28 ▼ $3.43	$1.15B	0.9	1.34 million shs	732,615 shs
FRX Fennec Pharmaceuticals	C$17.01	C$14.33	C$7.59 ▼ C$17.64	C$590.88M	3.548856	1,233 shs	403 shs
MJN Cronos Group	C$12.15 -1.9%	C$12.15	C$1.58 ▼ C$14.83	C$1.73B	N/A	2.07 million shs	1.39 million shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CARA Cara Operations	0.00%	0.00%	0.00%	0.00%	0.00%
CRON Cronos Group	-0.32%	+2.93%	+14.91%	+20.15%	+20.61%
FRX Fennec Pharmaceuticals	+3.03%	+13.40%	+15.01%	+27.80%	+35.97%
MJN Cronos Group	0.00%	0.00%	0.00%	0.00%	0.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CARA Cara Operations	0.00	N/A	N/A	N/A
CRON Cronos Group	2.40	Hold	$2.30	-26.16% Downside
FRX Fennec Pharmaceuticals	4.00	Strong Buy	N/A	N/A
MJN Cronos Group	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest FRX, MJN, CARA, and CRON Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
8/12/2026	CRON Cronos Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C+)
5/29/2026	CRON Cronos Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)

(Data available from 8/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CARA Cara Operations	N/A	N/A	N/A	N/A	N/A	N/A
CRON Cronos Group	$146.59M	7.88	$0.01 per share	252.85	$3.01 per share	1.03
FRX Fennec Pharmaceuticals	C$51.00M	11.59	C$1.46 per share	11.66	C$1.23 per share	13.85
MJN Cronos Group	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CARA Cara Operations	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CRON Cronos Group	-$9.45M	$0.20	15.53	N/A	N/A	39.08%	4.85%	4.62%	N/A
FRX Fennec Pharmaceuticals	-C$800.44K	-C$0.29	N/A	N/A	N/A	-6.21%	-13.34%	8.88%	N/A
MJN Cronos Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest FRX, MJN, CARA, and CRON Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/6/2026	Q2 2026	CRON Cronos Group	$0.01	$0.09	+$0.08	$0.09	$44.20 million	$53.01 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CARA Cara Operations	C$0.41	1.54%	N/A	N/A	N/A
CRON Cronos Group	N/A	N/A	N/A	N/A	N/A
FRX Fennec Pharmaceuticals	N/A	2.02%	N/A	N/A	N/A
MJN Cronos Group	C$1.65	13.58%	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CARA Cara Operations	N/A	N/A	N/A
CRON Cronos Group	N/A	16.18	15.25
FRX Fennec Pharmaceuticals	N/A	5.85	10.17
MJN Cronos Group	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CARA Cara Operations	N/A
CRON Cronos Group	8.71%
FRX Fennec Pharmaceuticals	14.53%
MJN Cronos Group	N/A

Insider Ownership

Company	Insider Ownership
CARA Cara Operations	N/A
CRON Cronos Group	7.80%
FRX Fennec Pharmaceuticals	16.20%
MJN Cronos Group	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CARA Cara Operations	80	58.57 million	N/A	Not Optionable
CRON Cronos Group	450	370.73 million	341.81 million	Optionable
FRX Fennec Pharmaceuticals	10	34.74 million	N/A	Not Optionable
MJN Cronos Group	7,600	142.65 million	N/A	Not Optionable

FRX, MJN, CARA, and CRON Headlines

Recent News About These Companies

Cronos Group (CVE:MJN) Share Price Passes Below 50 Day Moving Average - Here's What Happened

August 12 at 4:05 AM | americanbankingnews.com

Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles

July 21, 2026 | financialpost.comF

Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026

July 16, 2026 | financialpost.comF

Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada

June 30, 2026 | financialpost.comF

Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders

June 22, 2026 | financialpost.comF

Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange

June 16, 2026 | financialpost.comF

Spinach® is the Number One Vape Brand in Canada

June 11, 2026 | financialpost.comF

Cronos Group Inc. (CRON) Stock Falls on Q1 2026 Earnings

May 11, 2026 | quiverquant.comQ

Cronos Expands Pre-Roll Portfolio with Spinach STIX®

May 6, 2026 | financialpost.comF

Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders

April 29, 2026 | financialpost.comF

Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026

April 20, 2026 | financialpost.comF

Cronos Group Inc. (CRON) Earns Buy Rating and C$4.50 PT on Scalable Model

March 3, 2026 | insidermonkey.com

Canaccord is Bullish on Cronos Group Inc. (CRON)

February 16, 2026 | finance.yahoo.com

Canaccord is Bullish on Cronos Group Inc. (CRON)

February 16, 2026 | insidermonkey.com

Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026

February 12, 2026 | financialpost.comF

Bernstein Reiterates Hold on Cronos Group Inc. (CRON) as Cash-Rich Balance Sheet Stands Out

January 25, 2026 | insidermonkey.com

Cronos Group reports Q3 EPS 7c vs 2c last year

November 6, 2025 | msn.com

Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025

October 23, 2025 | financialpost.comF

Cronos Group Releases 2025 Second Quarter Results

September 16, 2025 | insidermonkey.com

Cronos Token Jumps to Multi-Year Highs After Trump Media Partnership

August 28, 2025 | financefeeds.comF

New MarketBeat Followers Over Time

Media Sentiment Over Time

FRX, MJN, CARA, and CRON Company Descriptions

Cara Operations TSE:CARA

Cara Operations Limited operates and franchises full service restaurants. It operates through four segments: Corporate Restaurants, Franchise Restaurants, Food Processing and Distribution, and central operations. As of December 31, 2017, the company operated 1,272 restaurants, including 1,221 restaurants in Canada and 51 locations internationally under the Swiss Chalet, Harvey's, St-Hubert, Milestones, Montana's, Kelsey's, East Side Mario's, New York Fries, Prime Pubs, Bier Markt, Landing, Original Joe's, State & Main, Elephant & Castle, Burger's Priest, Pickle Barrel, Taverne Moderne, and The Keg restaurant brands. Cara Operations Limited was founded in 1883 and is headquartered in Vaughan, Canada.

Cronos Group NASDAQ:CRON

$3.12 -0.05 (-1.42%)

As of 03:05 PM Eastern

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Fennec Pharmaceuticals TSE:FRX

C$17.01 0.00 (0.00%)

As of 08/13/2026 11:06 AM Eastern

Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company committed to the fight against ototoxicity in cancer patients who receive cisplatin-based chemotherapy. Fennec is focused on the commercialization of PEDMARK® to reduce the risk of platinum-induced ototoxicity in cancer patients. PEDMARK received FDA approval in September 2022 and European Commission approval in June 2023 and United Kingdom ( U.K. ) approval in October 2023 under the brand name PEDMARQSI®. In March 2024, Fennec entered into an exclusive licensing agreement under which Norgine Pharmaceuticals Ltd., a leading European specialist pharmaceutical company, with rights to commercialize PEDMARQSI® in Europe, U.K., Australia and New Zealand. PEDMARQSI is now commercially available in the U.K. and Germany. PEDMARK has received Orphan Drug Exclusivity in the U.S. and PEDMARQSI has received Pediatric Use Marketing Authorization in Europe which includes eight years plus two years of data and market protection.

Cronos Group CVE:MJN

C$12.15 -0.23 (-1.86%)

As of 03/2/2018

Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada's Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc. and In The Zone Produce Ltd., are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals. Whistler Medical Marijuana is licensed to produce and sell medical marijuana, as well as cultivate cannabis oil. Hydropothecary is licensed to produce medical marijuana. Abcann Medicinals also has license to produce medical marijuana. With interest in five Licensed Producers and two LP applicants, it is focused on building brand portfolio providing patients with personalized care.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FRX, MJN, CARA, and CRON Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FRX, MJN, CARA, and CRON Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FRX, MJN, CARA, and CRON Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

FRX, MJN, CARA, and CRON Company Descriptions

Cara Operations TSE:CARA

Cronos Group NASDAQ:CRON

Fennec Pharmaceuticals TSE:FRX

Cronos Group CVE:MJN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FRX, MJN, CARA, and CRON Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FRX, MJN, CARA, and CRON Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FRX, MJN, CARA, and CRON Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

FRX, MJN, CARA, and CRON Company Descriptions

Cara Operations TSE:CARA

Cronos Group NASDAQ:CRON

Fennec Pharmaceuticals TSE:FRX

Cronos Group CVE:MJN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools